Esteve Pharmaceuticals` Thiotepa Riemser (Thiotepa) Approved In Europe
Fresenius Kabi announced today it has introduced Thiotepa for Injection, USP, in the United States. Thiotepa, a generic equivalent to Tepadina®, is the newest addition to the company’s injectable oncology portfolio – the most comprehensive in the industry.
Gland Pharma's Generic Thiotepa Receives Approval in the U.S.
Health Canada Issues Recall of Methapharm Inc`s Tepadina
MSN`s Generic Dofetilide Receives Approval in US
Dr. Reddys Labs Generic Thiotepa Receives Approval In US
Jiangsu Hengrui Med Generic Thiotepa Receives Approval In US
Thiotepa is now available through Amneal Biosciences in both 100 mg/vial and 15 mg/vial as branded TEPADINA® (thiotepa) for injection. The product is supplied as a powder for solution in single-dose vials for intravenous, intracavitary, or intravesical use.